Zobrazeno 1 - 10
of 24
pro vyhledávání: '"KAZUKI HASHIMOTO"'
Autor:
Rina Jiromaru, Ryuji Yasumatsu, Kazuki Hashimoto, Yui Nozaki, Yoshinao Oda, Takahiro Hongo, Takafumi Nakano, Hidetaka Yamamoto, Takashi Nakagawa
Publikováno v:
Histopathology. 79:358-369
AIMS p16 is a sensitive surrogate marker for transcriptionally active high-risk human papillomavirus (HR-HPV) infection in oropharyngeal squamous cell carcinoma (OPSCC), but it is not sufficient in all clinical settings. METHODS AND RESULTS We examin
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 39(26)
Autor:
Mayuko Miki, Koichi Hirokaga, Misao Soyama, Takuma Onoe, Kazuki Hashimoto, Koji Matsumoto, Minori Arase, Hideki Sakai, Meiko Nishimura, Shintaro Takao, Kaori Tane, Sayuri Watanabe
Publikováno v:
Anticancer Research. 39:4379-4383
Background/aim Dose-dense doxorubicin and cyclophosphamide (ddAC) followed by dose-dense paclitaxel (ddP) (ddAC-P) has improved disease-free survival of patients with breast cancer. The aim of this study was to evaluate the safety and relative dose i
Publikováno v:
JOURNAL OF JAPAN SOCIETY FOR HEAD AND NECK SURGERY. 28:271-276
Autor:
Mioko Matsuo, Rina Jiromaru, Muneyuki Masuda, Takashi Nakagawa, Hidetaka Yamamoto, Ryuji Yasumatsu, Kenichi Taguchi, Kazuki Hashimoto, Satoshi Toh, Yui Nozaki, Takahiro Wakasaki, Akihiro Tamae, Ryosuke Kuga, Yoshinao Oda, Takahiro Hongo
Publikováno v:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 34(11)
The antitumor efficacies of immune checkpoint inhibitors (ICIs) and the usefulness of potential predictive markers such as programmed death-ligand 1 (PD-L1) expression, density of tumor-infiltrating lymphocytes (TILs) and microsatellite instability (
Autor:
Akihiko Shimomura, Kazuki Hashimoto
Publikováno v:
Journal of Clinical Oncology. 39:1506-1507
Autor:
Ryuji Yasumatsu, Ryutaro Uchi, Muneyuki Masuda, Tomomi Manako, Mioko Matsuo, Kazuki Hashimoto, Toranoshin Takeuchi, Takashi Nakagawa, Takahiro Wakasaki, Rina Jiromaru
Publikováno v:
Acta oto-laryngologica. 140(12)
Significant immune-related adverse events (irAEs) requiring therapy discontinuation sometimes occur. The influence of discontinuation on disease control after an irAE is unclear.The aim of this study was to investigate whether or not patients continu
Autor:
Ryuji Yasumatsu, Muneyuki Masuda, Kazuki Hashimoto, Rina Jiromaru, Kuniaki Sato, Ryutaro Uchi, Tomomi Manako, Takashi Nakagawa, Takahiro Wakasaki, Satoshi Toh, Mioko Matsuo
Publikováno v:
Oral oncology. 113
Background Drug-induced interstitial lung disease (DI-IP) is one of the most serious adverse reactions associated with the use of anticancer drugs. DI-IP prevalence among molecular-targeting drugs and immune checkpoint inhibitors (ICIs) is relatively
Autor:
Masakazu Toi, Hiroyasu Yamashiro, Yuichiro Kikawa, Shintaro Takao, Takeshi Kotake, Yukiko Kajiwara, Shoichiro Ohtani, Kazuki Hashimoto
Publikováno v:
Breast Cancer: Basic and Clinical Research, Vol 13 (2019)
Breast Cancer : Basic and Clinical Research
Breast Cancer : Basic and Clinical Research
Purpose: To investigate the clinical predictive factors for the efficacy of everolimus (EVE) for advanced/metastatic breast cancer (AMBC). Methods: Routine practice data of consecutive patients with AMBC who received EVE at 5 institutions in western
Autor:
Takahiro Wakasaki, Tomomi Manako, Kazuki Hashimoto, Masahiko Taura, Mioko Matsuo, Koichiro Nakashima, Ryuji Yasumatsu, Takashi Nakagawa
Publikováno v:
Headneck. 41(8)
Background Predicting the response to treatment with nivolumab and the survival in patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) remains a challenge. We investigated whether or not the neutrophil-to-lymphocyte ra